BIOMAT Database Logo BIOMAT Database Logo

[Partial resection of the lungs in patients with newly detected destructive tuberculosis]. 1990

M A Ibragimov, and T M Kariev, and R A Kadyrova

The efficacy of partial pneumonectomies in 700 patients with newly-diagnosed destructive tuberculosis preceded by an ineffective antibacterial therapy for 3-15 months was studied. Operations were performed in 411 (58.8%) patients with fibrocavernous tuberculosis, in 173 (24.7%) with cavernous tuberculosis, in 10 (1.4%) with disseminated tuberculosis and cavitation, and in 106 (15.1%) with tuberculoma. Segmental resections were carried out in 214 (30.6%) cases, lobectomies in 309 (44.1%), and combined resections in 177 (25.3%). Immediately good and satisfactory clinical efficacy was achieved in 687 (98.1%) and 7 (1.0%) subjects respectively, the remaining 6 (0.9%) patients died. 3-15 years after the operation, the reactivation of tuberculosis was observed in 14 (2.3%) cases out of the 603 examined. An intensive antibacterial therapy as well as repeated operations made it possible to cure 6 patients, with 5 still under treatment and 3 dead. Later on a stable clinical cure was registered in 595 (98.7%) patients out of the 603 examined.

UI MeSH Term Description Entries
D008297 Male Males
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D011013 Pneumonectomy The excision of lung tissue including partial or total lung lobectomy. Bronchoscopic Lung Volume Reduction,Endoscopic Lung Volume Reduction,Lung Volume Reduction,Lung Volume Reduction Surgery,Partial Pneumonectomy,Partial Pneumonectomies,Pneumonectomies,Pneumonectomy, Partial,Reduction, Lung Volume,Volume Reduction, Lung
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

M A Ibragimov, and T M Kariev, and R A Kadyrova
[Bronchial patency of patients with newly detected destructive pulmonary tuberculosis].
January 1987, Problemy tuberkuleza,
M A Ibragimov, and T M Kariev, and R A Kadyrova
[Immunological status of newly detected patients with destructive pulmonary tuberculosis].
April 1979, Problemy tuberkuleza,
M A Ibragimov, and T M Kariev, and R A Kadyrova
[Newly diagnosed destructive tuberculosis of the lungs in patients with bronchial obstruction].
January 1985, Problemy tuberkuleza,
M A Ibragimov, and T M Kariev, and R A Kadyrova
[Diagnosis of bronchospasm in patients with newly detected destructive pulmonary tuberculosis].
January 1989, Problemy tuberkuleza,
M A Ibragimov, and T M Kariev, and R A Kadyrova
[Results of polychemotherapy in patients with newly detected destructive pulmonary tuberculosis].
January 1990, Problemy tuberkuleza,
M A Ibragimov, and T M Kariev, and R A Kadyrova
[State of bronchi in patients with newly detected destructive pulmonary tuberculosis].
September 1976, Problemy tuberkuleza,
M A Ibragimov, and T M Kariev, and R A Kadyrova
[Efficacy of intravenous chemotherapy of newly detected cases of destructive tuberculosis of the lungs].
January 1988, Problemy tuberkuleza,
M A Ibragimov, and T M Kariev, and R A Kadyrova
[BILATERAL PARTIAL RESECTION OF THE LUNGS IN PATIENTS WITH TUBERCULOSIS].
January 1963, Problemy tuberkuleza,
M A Ibragimov, and T M Kariev, and R A Kadyrova
[The efficacy of different chemotherapeutic regimens in patients over 50 years old with newly detected destructive tuberculosis of the lungs].
January 1990, Problemy tuberkuleza,
M A Ibragimov, and T M Kariev, and R A Kadyrova
[Diagnosis of chronic bronchitis in patients with newly detected destructive pulmonary tuberculosis].
January 1986, Problemy tuberkuleza,
Copied contents to your clipboard!